Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
Jun 23, 2026
HarbourVest Partners has taken a bold step by acquiring 1.7 million shares in Generate Biomedicines, betting $21 million on their fresh drug discovery platform.